Henry Schein, Inc. (NASDAQ:HSIC)‘s stock had its “hold” rating reissued by analysts at Jefferies Group LLC in a report issued on Friday. They currently have a $177.00 target price on the stock. Jefferies Group LLC’s price target suggests a potential downside of 4.03% from the company’s current price.

Other equities analysts have also issued reports about the company. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $206.00 price objective on the stock in a research report on Friday, June 16th. Stifel Nicolaus increased their price objective on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a research report on Wednesday, May 10th. Craig Hallum initiated coverage on Henry Schein in a research report on Tuesday, April 11th. They set a “hold” rating on the stock. Finally, Credit Suisse Group reiterated a “hold” rating and set a $160.00 price objective on shares of Henry Schein in a research report on Thursday, July 13th. Eleven analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Henry Schein has a consensus rating of “Hold” and an average target price of $183.40.

Henry Schein (HSIC) opened at 184.44 on Friday. Henry Schein has a 12 month low of $146.23 and a 12 month high of $186.99. The company’s 50-day moving average is $183.79 and its 200-day moving average is $172.80. The company has a market cap of $14.63 billion, a price-to-earnings ratio of 28.03 and a beta of 1.09.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 9th. The company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.65 by $0.11. The firm had revenue of $2.92 billion for the quarter, compared to analyst estimates of $2.83 billion. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The company’s revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.41 EPS. On average, equities research analysts anticipate that Henry Schein will post $7.28 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This article was reported by American Banking News and is owned by of American Banking News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/07/21/jefferies-group-llc-reaffirms-hold-rating-for-henry-schein-inc-hsic.html.

In other Henry Schein news, EVP Gerald A. Benjamin sold 12,578 shares of the stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the sale, the executive vice president now owns 44,061 shares in the company, valued at approximately $7,715,081.10. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 1.27% of the company’s stock.

Large investors have recently added to or reduced their stakes in the company. Oakbrook Investments LLC acquired a new stake in Henry Schein during the second quarter valued at $659,000. US Bancorp DE boosted its stake in Henry Schein by 3.3% in the second quarter. US Bancorp DE now owns 66,190 shares of the company’s stock valued at $12,113,000 after buying an additional 2,094 shares during the period. Anderson Hoagland & Co. boosted its stake in Henry Schein by 75.2% in the second quarter. Anderson Hoagland & Co. now owns 9,441 shares of the company’s stock valued at $1,728,000 after buying an additional 4,051 shares during the period. State Treasurer State of Michigan boosted its stake in Henry Schein by 0.4% in the second quarter. State Treasurer State of Michigan now owns 26,072 shares of the company’s stock valued at $4,772,000 after buying an additional 100 shares during the period. Finally, Aperio Group LLC boosted its stake in Henry Schein by 3.8% in the second quarter. Aperio Group LLC now owns 45,189 shares of the company’s stock valued at $8,270,000 after buying an additional 1,646 shares during the period. Institutional investors and hedge funds own 90.74% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.